Search research articles
Contact Us
Filters
Showing results (11-20 of 215) with videos related to
Page
of 22
Sort By:
British Medical Journal (Clinical Research Ed.)
|
May 28, 1983
Lymphomatoid granulomatosis
C Harrington, M Wood, N Rooney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 1991
Two-dimensional ordering of the DNA base guanine observed by scanning tunneling microscopy
W M Heckl, D P Smith, G Binnig, et al.
Organic & Biomolecular Chemistry
|
November 26, 2024
Asymmetric 'Clip-Cycle' synthesis of 3-spiropiperidines
Saikiran Ravi, Christopher J Maddocks, Ian J S Fairlamb, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine
|
August 8, 2018
Cancer-Specific Stress and Trajectories of Psychological and Physical Functioning in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Neha G Goyal, Kami J Maddocks, Amy J Johnson, et al.
Leukemia & Lymphoma
|
March 11, 2017
A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma
Jonathon B Cohen, Kami J Maddocks, Ying Huang, et al.
Organic & Biomolecular Chemistry
|
December 18, 2025
'Clip-Cycle' approaches to functionalised pyrrolidines, pyrrolizidines and indolizidines
Lee C Duff, Selin Yilmaz, Athanasia Agora, et al.
British Journal of Health Psychology
|
October 5, 2021
Illness representations and psychological outcomes in chronic lymphocytic leukaemia
Nicole A Arrato, Thomas R Valentine, John C Byrd, et al.
Cancer
|
May 15, 2018
Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemia
Barbara L Andersen, Neha Godiwala Goyal, David M Weiss, et al.
Blood Advances
|
May 23, 2024
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis
Michael Wang, Tadeusz Robak, Kami J Maddocks, et al.
Leukemia & Lymphoma
|
February 7, 2022
A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma
David A Bond, Ying Huang, Beth A Christian, et al.
Page
of 22
Search research articles
Search
Showing results (11-20 of 215) with videos related to
Sort By:
Page
of 22
British Medical Journal (Clinical Research Ed.)
|
May 28, 1983
Lymphomatoid granulomatosis
C Harrington, M Wood, N Rooney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 1991
Two-dimensional ordering of the DNA base guanine observed by scanning tunneling microscopy
W M Heckl, D P Smith, G Binnig, et al.
Organic & Biomolecular Chemistry
|
November 26, 2024
Asymmetric 'Clip-Cycle' synthesis of 3-spiropiperidines
Saikiran Ravi, Christopher J Maddocks, Ian J S Fairlamb, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine
|
August 8, 2018
Cancer-Specific Stress and Trajectories of Psychological and Physical Functioning in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Neha G Goyal, Kami J Maddocks, Amy J Johnson, et al.
Leukemia & Lymphoma
|
March 11, 2017
A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma
Jonathon B Cohen, Kami J Maddocks, Ying Huang, et al.
Organic & Biomolecular Chemistry
|
December 18, 2025
'Clip-Cycle' approaches to functionalised pyrrolidines, pyrrolizidines and indolizidines
Lee C Duff, Selin Yilmaz, Athanasia Agora, et al.
British Journal of Health Psychology
|
October 5, 2021
Illness representations and psychological outcomes in chronic lymphocytic leukaemia
Nicole A Arrato, Thomas R Valentine, John C Byrd, et al.
Cancer
|
May 15, 2018
Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemia
Barbara L Andersen, Neha Godiwala Goyal, David M Weiss, et al.
Blood Advances
|
May 23, 2024
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis
Michael Wang, Tadeusz Robak, Kami J Maddocks, et al.
Leukemia & Lymphoma
|
February 7, 2022
A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma
David A Bond, Ying Huang, Beth A Christian, et al.
Page
of 22